Published in J Neurochem on December 01, 1999
5-HT moduline: an endogenous inhibitor of 5-HT(1B/1D)-mediated contraction in pulmonary arteries. Br J Pharmacol (2003) 0.88
The long-term clinical course of acute deep venous thrombosis. Ann Intern Med (1996) 6.87
Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med (1997) 3.35
Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol (2001) 1.91
Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med (1999) 1.81
5-Hydroxytryptamine receptors. Pharmacol Rev (1992) 1.56
5-Hydroxytryptamine binding to synaptic membranes from rat brain. Life Sci (1976) 1.45
Use of an algorithm for administering subcutaneous heparin in the treatment of deep venous thrombosis. Ann Intern Med (1998) 1.41
The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica (1997) 1.39
Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience (1991) 1.26
Upper extremity deep vein thrombosis. Curr Opin Pulm Med (1999) 1.19
Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med (1994) 1.17
Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody. J Immunol Methods (1991) 1.06
Isolation and characterization of an endogenous peptide from rat brain interacting specifically with the serotonergic 1B receptor subtypes. J Biol Chem (1996) 1.02
High-affinity binding of (3H) 5-hydroxytryptamine to brain synaptosomal membranes: comparison with (3H) lysergic acid diethylamide binding. Mol Pharmacol (1978) 0.99
Rabies virus selectively alters 5-HT1 receptor subtypes in rat brain. Eur J Pharmacol (1993) 0.98
Specific interaction of 5-HT-moduline with human 5-HT1b as well as 5-HT1d receptors expressed in transfected cultured cells. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.95
Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty. Thromb Haemost (1992) 0.95
A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation (1993) 0.95
5-HT-moduline controls serotonergic activity: implication in neuroimmune reciprocal regulation mechanisms. Prog Neurobiol (2000) 0.92
Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis. Thromb Res (1997) 0.92
Expression of interleukin 1 alpha, interleukin 1 beta and interleukin 1 receptor antagonist mRNA in mouse brain: regulation by bacterial lipopolysaccharide (LPS) treatment. Brain Res Mol Brain Res (1995) 0.91
5-Hydroxytryptamine-moduline: a novel endogenous peptide involved in the control of anxiety. Neuroscience (1999) 0.91
Soil quality and vulnerability in a Mediterranean natural ecosystem of Central Italy. Chemosphere (2004) 0.90
Colonic metastasis of breast carcinoma. Hepatogastroenterology (2000) 0.89
Effects of stress on the functional properties of pre- and postsynaptic 5-HT1B receptors in the rat brain. Eur J Pharmacol (1995) 0.89
A method for cooperative or noncooperative binding studies using nonlinear regression analysis on a microcomputer. J Appl Biochem (1984) 0.89
Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen. Breast Cancer Res Treat (1998) 0.89
Effects of physical training on functional activity of 5-HT1B receptors in rat central nervous system: role of 5-HT-moduline. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.89
Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis. Thromb Haemost (1999) 0.88
The utility of non-invasive tests for detection of previous proximal-vein thrombosis. Thromb Haemost (1995) 0.88
Differential sensitivity of 5-HT1B auto and heteroreceptors. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.88
Estradiol increases the production of alpha 1-antichymotrypsin in MCF7 and T47D human breast cancer cell lines. Mol Cell Endocrinol (1985) 0.86
Clinical outcome of patients with internal carotid artery occlusion: a prospective follow-up study. J Vasc Surg (2000) 0.85
Regulation of interleukin-1 receptor expression in mouse brain and pituitary by lipopolysaccharide and glucocorticoids. Neuroendocrinology (1993) 0.85
Magnetic field desensitizes 5-HT(1B) receptor in brain: pharmacological and functional studies. Brain Res (2000) 0.85
Acute stress induces a differential increase of 5-HT-moduline (LSAL) tissue content in various rat brain areas. Brain Res (1999) 0.85
A sulphomucopolysaccharide-protein complex in the adrenergic vesicle (granule) fraction from nerves and tissue. Acta Physiol Scand (1972) 0.84
Pretransplant model for end-stage liver disease score as a predictor of postoperative complications after liver transplantation. Transplant Proc (2009) 0.84
5-HT1B receptors: a novel target for lithium. Possible involvement in mood disorders. Neuropsychopharmacology (1999) 0.84
5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors. Mol Pharmacol (1996) 0.84
Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by [3H]5-HT, in frontal cortex and the hippocampal region of the human brain. Brain Res (1994) 0.84
Contribution of cardiac MRI in the comprehension of peripartum cardiomyopathy pathogenesis. Int J Cardiol (2008) 0.83
Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. Transplant Proc (2010) 0.83
Characterization of 5-ht6 receptor and expression of 5-ht6 mRNA in the rat brain during ontogenetic development. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.83
Childhood loss in alcoholics and narcotic addicts. Br J Addict (1988) 0.83
Outcome of patients with suspected lower limb symptomatic deep vein thrombosis and a normal ultrasound-based initial diagnostic workup: a prospective study. J Thromb Haemost (2012) 0.82
5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes: further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.82
Nonspecific B and T cell-stimulatory activity mediated by mast cells is associated with exosomes. Int Arch Allergy Immunol (2001) 0.82
5-Hydroxytryptamine stimulates two distinct adenylate cyclase activities in rat brain: high-affinity activation is related to a 5-HT1 subtype different from 5-HT1A, 5-HT1B, and 5-HT1C. Fundam Clin Pharmacol (1988) 0.82
Autoradiographic characterization of [3H]-5-HT-moduline binding sites in rodent brain and their relationship to 5-HT1B receptors. Proc Natl Acad Sci U S A (1997) 0.82
Inhibition of [3H] gamma-aminobutyric acid release from guinea-pig hippocampal synaptosomes by serotonergic agents. Fundam Clin Pharmacol (1992) 0.82
Acute renal failure after liver transplantation in MELD era. Transplant Proc (2007) 0.81
Interleukin-1 receptors type I and type II in the mouse brain: kinetics of mRNA expressions after peripheral administration of bacterial lipopolysaccharide. J Neuroimmunol (1996) 0.81
Serotonin inhibits acetylcholine release from rat striatum slices: evidence for a presynaptic receptor-mediated effect. J Neurochem (1985) 0.81
Investigating synthetic P-regions from voltage-gated sodium channel at the conformational and functional levels. Eur Biophys J (1997) 0.81
Effects of 5-hydroxytryptamine on canine isolated coronary arteries. Br J Pharmacol (1982) 0.81
Postoperative troponin T elevation as a predictor of early acute kidney injury after orthotopic liver transplantation: a preliminary retrospective study. Transplant Proc (2012) 0.81
Comparison between the ventricular fibrillation thresholds of spontaneously hypertensive and normotensive rats--investigation of antidysrhythmic drugs. J Cardiovasc Pharmacol (1982) 0.81
Improved brain delivery of AZT using a glycosyl phosphotriester prodrug. J Med Chem (1992) 0.80
Expression of serotonin receptors in human fetal astrocytes and glioma cell lines: a possible role in glioma cell proliferation and migration. Brain Res Mol Brain Res (1996) 0.80
Immunocytochemical localization of neurons expressing 5-HT-moduline in the mouse brain. Neuropharmacology (1997) 0.80
Quantitative autoradiography of 5-HT1E binding sites in rodent brains: effect of lesion of serotonergic neurones. Eur J Pharmacol (1993) 0.80
Decrease in internal H+ and positive inotropic effect of heptaminol hydrochloride: a 31P n.m.r. spectroscopy study in rat isolated heart. Br J Pharmacol (1989) 0.80
Magnetic field (50 Hz) increases N-acetyltransferase, hydroxy-indole-O-methyltransferase activity and melatonin release through an indirect pathway. Int J Radiat Biol (2003) 0.79
Endurance training effects on 5-HT(1B) receptors mRNA expression in cerebellum, striatum, frontal cortex and hippocampus of rats. Neurosci Lett (2001) 0.78
Endoproteolytic activity in mammalian brain membranes cleaves 5-hydroxytryptamine-moduline into dipeptides. Eur J Pharmacol (1999) 0.78
The in situ hybridization and immunocytochemistry techniques for characterization of cells expressing specific mRNAs in paraffin-embedded brains. Brain Res Brain Res Protoc (1997) 0.78
Molecular, cellular and physiological characteristics of 5-HT-moduline, a novel endogenous modulator of 5-HT1B receptor subtype. Ann N Y Acad Sci (1998) 0.78
Psittacosis outbreak after participation in a bird fair, Western France, December 2008. Epidemiol Infect (2011) 0.78
The endogenous cerebral tetrapeptide 5-HT-moduline reduces in vivo the functional activity of central 5-HT1B receptors in the rat. Neurosci Res (1997) 0.78
Autoradiographic localization of 5-HT1E and 5-HT1F binding sites in rat brain: effect of serotonergic lesioning. J Recept Signal Transduct Res (1997) 0.78
Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis. Eur J Vasc Endovasc Surg (2000) 0.78
Stress-induced 5-HT1A receptor desensitization: protective effects of Ginkgo biloba extract (EGb 761). Fundam Clin Pharmacol (1995) 0.78
Symptomatic deep-vein thrombosis and the post-thrombotic syndrome. Haematologica (1995) 0.78
The effects of inorganic lead on the spontaneous and potassium-evoked release of 3H-5-HT from rat cortical synaptosome interaction with calcium. Pharmacol Toxicol (1989) 0.78
Effect of tuamine, heptaminol and two analogues on uptake and release of catecholamines in cultured chromaffin cells. Biochem Pharmacol (1990) 0.77
The inhibitory effect of trifluoromethylphenylpiperazine on [3H]acetylcholine release in guinea pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine1 receptor distinct from 1A, 1B, and 1C subtypes. J Neurochem (1991) 0.77
5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.77
Serotonin sensitive adenylate cyclase in horse brain synaptosomal membranes. Life Sci (1979) 0.77
[3H]5-HT binding sites and 5-HT-sensitive adenylate cyclase in glial cell membrane fraction. Brain Res (1980) 0.77
Characterization and distribution of receptors for gonadotropin-releasing hormone in the rat hippocampus. Neuroendocrinology (1988) 0.77
5-HT and LSD high affinity binding sites to brain synaptosomal membranes [proceedings]. Br J Pharmacol (1976) 0.77